Target intelligence / Profile preview

Myosin XVI (MYO16)

Target
MYO16
Molecular classification
Unconventional myosin, actin-based motor protein, scaffolding/adaptor protein
01

Overview

Myosin XVI (MYO16) is an unconventional, neuronally expressed myosin that binds actin filaments and plays a specific role in the regulation of actin cytoskeleton dynamics particularly in dendritic spines of neurons[1][2]. It contains an N-terminal ankyrin repeat domain that interacts with protein phosphatase 1 catalytic subunits, a myosin motor domain (likely with impaired ATPase activity), and a tail region that interacts with both phosphoinositide 3-kinase (PI3K) and the WAVE regulatory complex (WRC), thereby functioning as an adaptor linking signaling complexes that control actin polymerization[1]. MYO16 is critical for normal presynaptic organization in the cerebellum and may regulate neuronal morphogenesis by activating PI3K and recruiting the WAVE1 complex[1][2]. Genetic variants are linked with risk for neuropsychiatric disorders including schizophrenia and autism spectrum disorder, and upregulation of MYO16 has been observed in the frontal cortex of schizophrenia patients[2]. This protein does not serve as a typical receptor, enzyme, or known direct therapeutic target, and no interacting drugs or disease biomarkers are established at this time[2][3].

Other names
Unconventional myosin-16KIAA0865MYO16BNYAP3MYR8Myo16bPPP1R107neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 3neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 3protein phosphatase 1 regulatory subunit 107
02

Biological functions

Actin cytoskeleton regulationSynaptic organizationNeuronal morphogenesisCell cycle progression
03

Disease associations

Neuropsychiatric disease (autism spectrum disorder)Neuropsychiatric disease (schizophrenia)Cancer (prostate)

Beyond the preview

Go deeper on Myosin XVI (MYO16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myosin XVI (MYO16).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call